Trials / Completed
CompletedNCT03841435
Hypofractionated Radiotherapy for Recurrent DIPG
Feasibility Study of Hypofractionated Radiotherapy in the Setting of Recurrent Diffuse Intrinsic Pontine Glioma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the feasibility of hypofractionated radiotherapy (RT) in the palliative treatment of recurrent diffuse intrinsic pontine glioma (DIPG). Participants will receive 15 Gy in 3 fractions as opposed to the standard 20 Gy in 10 fractions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Hypofractionated Radiotherapy | Radiotherapy Treatment, totaling 15 Gy, will be given in 3 fractions over 2 weeks. |
Timeline
- Start date
- 2018-01-31
- Primary completion
- 2023-03-03
- Completion
- 2023-03-03
- First posted
- 2019-02-15
- Last updated
- 2023-09-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03841435. Inclusion in this directory is not an endorsement.